- Home
- DGLY vs TCBP Comparison
DGLY vs TCBP Comparison
Compare DGLY & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- TCBP
- Stock Information
- Founded
- DGLY 2004
- TCBP 2013
- Country
- DGLY United States
- TCBP United Kingdom
- Employees
- DGLY N/A
- TCBP N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DGLY Technology
- TCBP Health Care
- Exchange
- DGLY Nasdaq
- TCBP Nasdaq
- Market Cap
- DGLY 3.5M
- TCBP 3.0M
- IPO Year
- DGLY N/A
- TCBP 2022
- Fundamental
- Price
- DGLY $0.56
- TCBP $0.65
- Analyst Decision
- DGLY
- TCBP Strong Buy
- Analyst Count
- DGLY 0
- TCBP 1
- Target Price
- DGLY N/A
- TCBP $3.00
- AVG Volume (30 Days)
- DGLY 186.6K
- TCBP 1.8M
- Earning Date
- DGLY 12-27-2024
- TCBP 02-09-2025
- Dividend Yield
- DGLY N/A
- TCBP N/A
- EPS Growth
- DGLY N/A
- TCBP N/A
- EPS
- DGLY N/A
- TCBP N/A
- Revenue
- DGLY $23,417,110.00
- TCBP N/A
- Revenue This Year
- DGLY $22.14
- TCBP N/A
- Revenue Next Year
- DGLY N/A
- TCBP N/A
- P/E Ratio
- DGLY N/A
- TCBP N/A
- Revenue Growth
- DGLY N/A
- TCBP N/A
- 52 Week Low
- DGLY $0.51
- TCBP $0.44
- 52 Week High
- DGLY $3.29
- TCBP $41.50
- Technical
- Relative Strength Index (RSI)
- DGLY 33.18
- TCBP 36.84
- Support Level
- DGLY $0.51
- TCBP $0.45
- Resistance Level
- DGLY $0.78
- TCBP $0.70
- Average True Range (ATR)
- DGLY 0.10
- TCBP 0.08
- MACD
- DGLY -0.01
- TCBP 0.10
- Stochastic Oscillator
- DGLY 14.17
- TCBP 55.58
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.